The Abstract Submission is closed.

Abstract submission was available from 31.03. - 25.07.2023.

- Abstract Guidelines | - Structure of Abstract | - Form of Presentation |
- Abstract Rating / Notification / Publication

Abstract Guidelines

  • The scientific committee highly encourages the submission of original scientific material
  • Abstracts for SNS have to be written and presented in English.
  • Abstracts for SSNS can be written and presented in English (preferred), German or French
  • Can be submitted again: abstracts that have been presented at a foreign congress during the last year
  • Cannot be submitted again: abstracts that have been published in a journal and abstracts that have been submitted at an earlier congress of an involved society
  • Abstracts have to be submitted in English
  • At least one author has to be registered for the congress
  • Pharmaceutical abstracts are only accepted when Swiss neurologists have played a major role (first or last author) and actually did the work.

Structure of the Abstract

If applicable, the abstract should consist of the following parts:

    1. Title
      • please do not use only capital letters - for example please write "Swiss Neurological Society " and NOT "SWISS NEUROLOGICAL SOCIETY"
      • if your abstract contains a case report, please indicate in the title
    2. The content of the abstract
      (limited to 2500 characters including spaces) should consist of the following parts:
      • Aims
      • Methods
      • Results - Arithmetic characters are to be separated with spaces. Example: Permitted is the notation "p < 0.5", whereas "p<0.5" is not permitted
      • Conclusion
    3. Authors - please include all authors in the correct order
    4. Affiliations - please include the authors’complete affiliations by indicating the corresponding company/institutions, department, location and country
    5. Acknowledgements or references - can be added in the separate field below the abstract body/content.
    6. References - should be indicated using the following format: author name, journal name, year of publication, volume, starting page, without manuscript title; e.g. (Smith AG. et al. J Fant 2002:79:567).
    7. Please note that figures, tables or graphs cannot be included.

Form of Presentation

Abstracts will be selected for:
- ePoster (SNS & SSNS)
- Poster flash sessions** (SSNS & SNS)
- Free Communication (SSNS only)
- The best abstracts (SSNS & SNS) will be presented in the plenary sessions. 

**In addition to the ePoster some abstracts will be selected for a short oral presentation during the ePoster Sessions which will take place in the lectures halls (laptop & beamer provided) on Thursday, 23.11.2023 
Each presentation is scheduled for 4 minutes (3' presentation + 1' discussion), max 3 slides

Abstract Rating

Submitted abstracts will be evaluated by the abstract jury including the members of the scientific committee after the submission deadline.

Abstract Notification

Acceptance of the abstracts will be communicated to the corresponding / submitting author middle of August 2023.
Co-authors or presenters will not be notified and have to be informed by the corresponding/submitting author.

Abstract Publication

Accepted abstracts will be published on the website and as eJournal in the CTN Journal "Clinical and Translational Neuroscience".

Contact

Should you require further help with your abstract submission or have any questions, please contact the IMK congress secretariat: abstracts@imk.ch | congress@imk.ch